Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang CONBA Pharmaceutical Co Ltd Announces FY 2013 Q1 Net Profit Outlook


Tuesday, 2 Apr 2013 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd announced that it expects its net profit for the first quarter of fiscal year (FY) 2013 to increase 100% ~ 120%, compared to the net profit of the same period in FY 2012 (RMB 46,490,475.32). The Company cited the increase of sales proceeds for most of its products, gain on acquire of Yunnan-based company, gain on selling of equities, as well as reception of government subsidy as the main reasons for the forecast.